HEPA Hepion Pharmaceuticals, Inc.
Healthcare · Pharmaceutical Preparations · Market cap: $10.3M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $34.4K | $0 |
| 2023-Q4 | $15.4K | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $400.0K | $0 |
| 2026-Q3 | $835.0K | $0 |
| 2026-Q4 | $0 | $0 |
Bought$1.3M16 buy days
Sold$00 sell days
Net insider flow+$1.3Mnet buying · 5 years
Latest trade2026-09-29Fisher Danina
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-09-29 | Buy | Fisher Danina | Director | 200,000 | $0.05 | $10.0K | 1 |
| 2026-08-03 | Buy | LoPriore Vincent S | Chair | 10,000,000 | $0.05 | $500.0K | 2 |
| 2026-08-03 | Buy | Stetz Gary S. | CEO | 2,000,000 | $0.05 | $100.0K | 1 |
| 2026-08-03 | Buy | Purcell Michael J. | Director | 2,000,000 | $0.05 | $100.0K | 1 |
| 2026-08-03 | Buy | Appajosyula Sireesh | COO | 2,000,000 | $0.05 | $100.0K | 1 |
| 2026-08-03 | Buy | Stetz Gary S. II | Director | 500,000 | $0.05 | $25.0K | 1 |
| 2026-04-21 | Buy | LoPriore Vincent S | Chair | 6,250,000 | $0.04 | $250.0K | 2 |
| 2026-04-21 | Buy | Appajosyula Sireesh | Director | 1,250,000 | $0.04 | $50.0K | 1 |
| 2026-04-21 | Buy | Stetz Gary S. | CEO | 1,250,000 | $0.04 | $50.0K | 1 |
| 2026-04-21 | Buy | Purcell Michael J. | Director | 1,250,000 | $0.04 | $50.0K | 1 |
| 2023-11-27 | Buy | Wijngaard Peter | Director | 2,500 | $3.05 | $7.6K | 1 |
| 2023-11-24 | Buy | Wijngaard Peter | Director | 2,500 | $3.09 | $7.7K | 1 |
| 2023-09-19 | Buy | Wijngaard Peter | Director | 1,000 | $5.64 | $5.6K | 1 |
| 2023-09-18 | Buy | Foster Robert T | CEO | 1,600 | $5.60 | $9.0K | 1 |
| 2023-09-15 | Buy | Wijngaard Peter | Director | 2,000 | $5.60 | $11.2K | 3 |
| 2023-09-15 | Buy | Foster Robert T | CEO | 1,600 | $5.40 | $8.6K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| LoPriore Vincent S | Chair | $750.0K | $0 | 2026-08-03 |
| Appajosyula Sireesh | COO | $150.0K | $0 | 2026-08-03 |
| Purcell Michael J. | Director | $150.0K | $0 | 2026-08-03 |
| Stetz Gary S. | CEO | $150.0K | $0 | 2026-08-03 |
| Wijngaard Peter | Director | $32.2K | $0 | 2023-11-27 |
| Stetz Gary S. II | Director | $25.0K | $0 | 2026-08-03 |
| Foster Robert T | CEO | $17.6K | $0 | 2023-09-18 |
| Fisher Danina | Director | $10.0K | $0 | 2026-09-29 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2026-08-03 | 5 | $825.0K | 48 | +13.6% (+7.7% raw) | – | – | active |
| 2026-04-21 | 4 | $400.0K | 62 | -17.2% (-12.3% raw) | -38.9% (-33.5% raw) | +92.5% (+95.7% raw) | closed |
| 2021-02-16 → 2021-02-18 | 3 | $82.0K | 51 | -10.9% (-9.7% raw) | -24.8% (-26.0% raw) | -35.8% (-40.2% raw) | closed |
| 2020-11-25 → 2020-12-18 | 5 | $115.6K | 56 | +27.3% (+34.8% raw) | -2.3% (+17.4% raw) | -8.3% (+18.0% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.